Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

Please provide your email address to receive an email when new articles are posted on . Use of a precision navigator led to significant increase in genomic profiling among men with prostate cancer.

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

The National Comprehensive Cancer Network recommends germline genetic testing for patients with prostate cancer and high-risk features or a suggestive family history. In 2024, the University of ...

GPs and neighbourhood teams will pilot genomic testing in primary care to predict the likelihood of specific conditions.

Beyond BRCA: Real-world outcomes with poly(ADP-ribose) polymerase inhibitors among patients with metastatic castration-resistant prostate cancer and homologous recombination repair mutations.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...